openPR Logo
Press release

Carglumic Acid Market Projected to Reach US$ 314.4 Million by 2033 with a CAGR of Over 7.5%

06-18-2024 04:05 PM CET | Science & Education

Press release from: FactMR

Carglumic Acid Market Projected to Reach US$ 314.4 Million

Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033.

Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation of ammonia in the blood, which can be life-threatening. The Carglumic acid market has been witnessing growth due to increasing awareness of rare genetic disorders, advancements in healthcare infrastructure, and supportive government policies.

Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=7068

Market Dynamics

Drivers

Increasing Prevalence of Genetic Disorders: With the rise in genetic screening and diagnostic techniques, the identification of metabolic disorders like NAGS deficiency has increased. This has driven the demand for specific treatments such as carglumic acid.

Advancements in Biotechnology: Innovations in biotechnological research have improved the production and efficacy of carglumic acid, making treatments more accessible and effective.

Government Support and Funding: Many governments provide funding and support for research and development of treatments for rare diseases. This support has facilitated the growth of the carglumic acid market.

Restraints

High Cost of Treatment: The production of carglumic acid is complex and costly, which translates to high treatment costs. This can limit its accessibility, particularly in low-income regions.

Limited Awareness: Despite improvements, there is still limited awareness about NAGS deficiency and its treatment options, which can restrict market growth.

Market Segmentation

By Dosage Form

Tablets: Tablets are the most common form of carglumic acid available in the market. They are preferred due to their convenience and precise dosage.

Dispersible Tablets: These are designed to dissolve in water, making them easier to administer, especially for pediatric and elderly patients who may have difficulty swallowing tablets.

By Application

NAGS Deficiency: The primary application of carglumic acid is in the treatment of NAGS deficiency. It is used to lower ammonia levels in the blood, preventing the severe consequences of hyperammonemia.

Other Hyperammonemia Conditions: Carglumic acid is also being explored for use in other conditions that cause elevated ammonia levels, broadening its potential market.

By Region

North America: This region dominates the carglumic acid market due to advanced healthcare infrastructure, high awareness, and substantial government support for rare disease treatments.

Europe: Europe is another significant market, driven by strong healthcare systems and funding for rare disease research.

Asia-Pacific: The market in this region is growing due to increasing healthcare investments and rising awareness about genetic disorders.

Rest of the World: Other regions are gradually catching up as awareness and healthcare infrastructure improve.

Competitive Landscape

The carglumic acid market is moderately competitive, with key players focusing on research and development, strategic partnerships, and mergers and acquisitions to enhance their market presence. Some prominent players include:

Orphan Europe (Recordati Group): A leading player in the market, Orphan Europe, specializes in treatments for rare diseases and has a significant presence in the carglumic acid market.

Civentichem LLC: This company is involved in the production and distribution of carglumic acid, focusing on expanding its reach and improving product availability.

AN PharmaTech: A key manufacturer of active pharmaceutical ingredients (APIs), including carglumic acid, AN PharmaTech plays a crucial role in the supply chain.

Future Outlook

The carglumic acid market is expected to continue growing, driven by ongoing advancements in genetic research, increasing prevalence of metabolic disorders, and expanding healthcare infrastructure globally. Additionally, initiatives to raise awareness about rare genetic disorders and their treatment options will likely boost market growth.

Innovations and Research

Future developments in the carglumic acid market may include:

Improved formulations for enhanced efficacy and patient compliance.

Research into broader applications for carglumic acid in treating other hyperammonemia conditions.

Development of cost-effective production methods to make treatments more affordable.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7068

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carglumic Acid Market Projected to Reach US$ 314.4 Million by 2033 with a CAGR of Over 7.5% here

News-ID: 3543437 • Views:

More Releases from FactMR

Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research Infrastructure
10-08-2025 | Health & Medicine
FactMR
Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research …
The biobanking industry stands at the threshold of a decade-long expansion trajectory that promises to reshape biological sample storage and research infrastructure technology. The market's journey from USD 68.5 billion in 2025 to USD 147.9 billion by 2035 This expansion underscores the industry's pivotal role in modernizing biological sample storage and advancing research infrastructure for pharmaceutical and biotechnology applications. Biobanking's critical contribution to personalized medicine, drug discovery, and disease research positions
Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveiling a Decade of Transformative Growth for Drug Safety and Packaging Innovation
10-08-2025 | Health & Medicine
FactMR
Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveil …
The global Biopharmaceutical Packaging Market is entering a decade of unprecedented expansion, set to nearly double in size from USD 28.5 billion in 2025 to USD 58.2 billion by 2035, registering a robust CAGR of 7.4%. This remarkable growth reflects the rising demand for advanced pharmaceutical packaging systems that enhance sterility, improve drug safety, and streamline regulatory compliance. The market's trajectory is not just about scaling revenue but also about reshaping
3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecast to Reach USD 18.8 billion by 2035
10-08-2025 | Health & Medicine
FactMR
3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecas …
The 3D printing in healthcare industry stands at the threshold of a decade-long expansion trajectory that promises to reshape medical manufacturing and personalized healthcare technology. The market's journey from USD 4.2 billion in 2025 to USD 18.8 billion by 2035This remarkable growth underscores the technology's pivotal role in advancing personalized medicine, surgical precision, and medical device manufacturing, making it an investment priority for forward-looking manufacturers and healthcare technology leaders.Driven by
Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growing at 32.0% CAGR
10-08-2025 | Health & Medicine
FactMR
Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growi …
The global surgical navigation glasses market is expected to reach USD 6,793 Million by 2035, up from estimated value of USD 423.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 32.0%.This exponential trajectory underscores the industry's pivotal role in transforming modern surgical practices, particularly in neurosurgery, orthopedics, and minimally invasive procedures. Fueled by the rapid adoption of Augmented Reality

All 5 Releases


More Releases for Carglumic

Carglumic Acid Market is Expanding Rapidly with Promising Growth Prospects
Carglumic Acid Market latest research report added by USD Analytics. The Carglumic Acid Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in the future.
Carglumic Acid Market, Scenario Highlighting Growth and Major Drivers by 2021-20 …
Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. The global pharmaceutical and healthcare industry is characterized by constant innovation and the development of new treatment options. One such innovative product that has gained attention in recent years is Carglumic Acid, a medication used in the treatment of
Carglumic Acid Market to Witness Huge Growth by 2028
Carglumic Acid market research report assists different industries to understand customer behavior towards particular product or service launch. It carries out detailed research and provides important market data about consumers. It assists different industries to formulate different strategies for expansion of business and increase the product portfolio in the marketplace. It aims at offering valuable market data to make effective decision. All the significant data provided here covers prediction of
Carglumic Acid Market Analysis, Status and Business Outlook 2017 to 2026
The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research (TMR). Carglumic acid is used to manufacture several forms of therapeutic tablets, and this is a key standpoint from the perspective of market growth. Read Report Overview - https://www.transparencymarketresearch.com/carglumic-acid-market.html The leading vendors in the global carglumic acid market have set on a spree to tie up with new
Carglumic Acid Market Analysis, Applications, Sale, Growth Insight, Trends By 20 …
LOS ANGELES, UNITED STATE: – The report on the global Carglumic Acid market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global  Carglumic Acid Market. It offers a detailed analysis of the competition and leading companies of
Carglumic Acid Market Witness Widespread Expansion by 2026
Transparency Market Research (TMR) has compiled a new comprehensive report on the global carglumic acid market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data